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1. Introduction 
Benzimidazole derivatives having wide interest because of 
their diverse biological activities and clinical applications. They are 
remarkably effective compounds with respect to their activity [1-3]. The 
importance of benzimidazole nucleus, it would be worthwhile to design 
and synthesize some benzimidazole derivatives and screen them for 
potential biological activities. Resistance to various antimicrobial drugs 
(β-lactam antibiotics, macrolides, quinolones, and vancomycin) among a 
variety of clinically significant species of bacteria is becoming 
increasingly important problems. Increasing drug resistance is a 
significant health matter. Benzimidazole ring displays an important 
heterocyclic pharmacophore in drug discovery, these compounds 
carrying different substituent in the benzimidazole structure are 
connected with a wide range of pharmacological activities such as anti-
cancer, antiviral, antibacterial, antifungal, antihelmintic, 
antiinflammatory, antihistaminic, analgesic, proton pump inhibitor, 
antioxidant, antihypertensive, anticoagulant  and other properties [4]. 
The different substituted benzimidazole derivatives are exhibited 
proton pump inhibitor actions, such as omeprazole, lansoprazole, 
rabeprazole, and pantoprazole [5]. In recent years, attention has 
increasingly been given to the synthesis of benzimidazole derivatives. 
The synthesis of novel benzimidazole derivatives remains a main focus 
of medicinal research. Recent observations suggest that substituted 
benzimidazoles and heterocyclic, show easy interactions with the 
biopolymers, possess potential activity with lower toxicities in the 
chemotherapeutic approach in man [6].  
 
2. Benzimidazole 
The benzimidazoles contain a phenyl ring fused to an 

















Compound R R1 R2 R3 
 Omeprazole  OCH3 CH3 OCH3 CH3 
 Lansoprazole  H CH3 OCH2CF3 H 
 Rabeprazole  H CH3 (CH2)OCH3 CF3 
 Pantoprazole  OCHF2 OCH3 OCH3 H 
 
3. Importance of heterocyclic compounds as 
antimicrobial agents  
Antimicrobial agents are the drugs, chemicals, or other 
substances that kill or slow the growth of microbes. They include 
antibacterial drugs, antiviral agents, antifungal agents, antiparasitic 
drug [7]. Antimicrobial chemotherapy has been the main stay of medical 
intervention against infectious diseases caused by various pathogens. 
Numerous classes of antimicrobial drugs have been discovered, and 
hundreds of drugs are available for use today. Antimicrobials are among 
the most commonly used of all drugs [8]. Since the introduction of 
penicillin, antimicrobials have a history of success in controlling 
morbidity due to infectious diseases [9]. The regular use of 
antimicrobial agents causes various problems such as toxicity, 
hypersensitivity reactions, drug resistance, superinfection (supra-
infection), nutritional deficiencies and masking of an infection [10]. The 
incidence of invasive microbial infections caused by opportunistic 
pathogens, often characterized by high mortality rates, has been 
increasing past two decades. Patients who become severely immune-
compromised because of underlying diseases such as leukemia or 
recently acquired immunodeficiency syndrome or patients who undergo 
cancer chemotherapy or organ transplantation are particularly 
susceptible to opportunistic microbial infection. Almost all major classes 
of antibiotics have encountered resistance in clinical applications. The 
emergence of bacterial resistance to β-lactam antibiotics, macrolides, 
quinolones and vancomycin is becoming a major worldwide health 
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problem. A matter of concern in the treatment of microbial infections is 
the limited number of efficacious antimicrobial drugs. Many of the 
currently available drugs are toxic, enable recurrence because they are 
bacteriostatic or fungistatic and not bactericidal or fungicidal or lead to 
the development of resistance due in part to the prolonged periods of 
administration. There is a real perceived need for the discovery of new 
compounds that are endowed with antimicrobial activities, possibly 
acting through mechanisms of action, which are distinct from those of 
well known classes of antimicrobial agents to which many clinically 
relevant pathogens are now resistant. It is therefore critical to realize 
that antimicrobial drug effectiveness, widely accepted as a common 
good, its increasing resistance cannot be taken for granted. Thus, an 
urgent need for new potent classes of antibiotics with novel modes of 
action persists [11]. The biological activity of the compounds is mainly 
dependent on their molecular structures [12]. Heterocyclic compounds 
are acquiring more importance in recent years as these can be found in a 
large number of compounds which display biological activity [13]. 
Heterocyclic compounds particularly five and six member heterocycles 
have attracted the attention of pharmaceutical community over the 
years due to their therapeutic value [14]. Polyfunctionalized 
heterocyclic compounds containing Nitrogen, sulphur, oxygen as 
heteroatoms play important roles in the drug discovery process [15]. 
Analysis of drugs in late development stages or in the market shows that 
68% of them are heterocycles [16]. Therefore, it is not surprising that 
during past decades, compounds bearing heterocyclic nuclei have 
received much attention due to their chemotherapeutic value in the 
development of novel antimicrobials and antihelmintics [17].  
Therefore, these heterocyclic compounds are being synthesized in terms 
of operational simplicity, non-toxicity, reusability, environment and 
economical acceptability.  
 
4. Biological activities of benzimidazole derivatives:  
Despite of the availability of a number of antimicrobial agents 
the main matter of concern in the treatment of microbial infections is 
the limited number of efficacious antimicrobial drugs [17]. Infectious 
microbial diseases remain pressing problems world-wide, because 
resistance to a number of antimicrobial agents among variety of 
clinically significant species of microorganisms has become an 
important global health problem. One way to battle with this challenge 
is the conscious usage of the currently marketed antibiotics; the other is 
the development of novel antimicrobial agents. Hence, there will always 
be a vital need to discover new therapeutic agents to avert the 
emergence of resistance and ideally shorten the time duration of 
therapy [18]. The outcome of numerous attempts to new structural 
prototype in the search for effective antimicrobials indicates that the 
benimidazoles still remain as one of the most versatile class of 
compounds against microbes [19]. Compounds bearing benzimidazoles 
moiety are reported to possess various interesting biological activities 
such as antitubercular, anticancer, anthelmintic, antiallergic, 
antioxidant, antihistaminic and antimicrobial [20]. In recent years 
benzimidazoles have been reported to act as topoisomerase-I inhibitors, 
selective neuropeptide YYI receptor antagonists, angitensin-II 
inhibitors, 5-HT3 antagonist, in the treatment of interstitial cystitis and 
as a factor Xa inhibitors [21].  
4.1 Benzimidazoles as Antimicrobials:  
The increase in bacterial resistance has attracted 
considerable interest in the discovery and develop-ment of new classes 
of anti-bacterial agents. The new agents should preferably consist of 
chemical characteristics that clearly differ from those of existing agents. 
Actinonin was first isolated from a Malayan strain of Actinomyces and 
found to show a weak inhibitory activity against Gram-positive and 
Gram-negative bacteria. However, recently actinonin has been proven to 
have anti-proliferative effects on human tumor cells. The action 
mechanism of actinonin is believed to be the inhibition of the peptide 
deformylase that is a new class of metal-loenzyme which is essential for 
bacterial survival. The hydroxamate group of actinonin, which can 
complex with the metal ion in the active pocket of the peptide 
deformylase, is necessary for its activity. Nevertheless, actinonin lacks in 
vivo efficacy, due to the poor bioavailability [22]. Second-generation 
macrolides such as clarithromycin (CAM) and azithromycin (AZM) have 
enjoyed widespread clinical use for the treatment of upper and lower 
respiratory tract infections as well as genital infections due to their 
superior anti-bacterial activity, pharmacokinetic properties and fewer 
gastrointestinal side (GI) effects compared with first generation 
macrolides such as erythromycin (EMA) which is its acid instability, 
leading to consequential degradation products responsible for its poor 
pharmacokinetic profile and GI side effects. Their mechanism of action 
has been elucidated that the macrolides bind reversibly to the 
nucleotide A2058 in domain V of the 23S rRNA in the ribosom-al 50S 
subunit and block protein synthesis. However, the therapeutic Utility of 
the macrolides has been severely compromised by the emergence of 
widespread bacterial resistance which has become a serious medical 
problem worldwide [23].  
A series of 1-methyl-N-[(substituted-phenylmethylidine)-H-
benzimidazole-2-amines (1) showed antibacterial and cytotoxic 
properties for Gram positive bacteria (S.aureus, B. pumillus) and Gram 
negative bacteria (E.coli) [24]. Some thieno[2,3-d]pyrimidin-4(3H)-ones 
(2) containing benzimidazol-2-yl-thioethyl and benzimidazol-2-yl-
methanethioethyl moiety in second position of pyrimidine ring were 















1                                               2 
In vitro antibacterial evaluation against Gram positive 
bacteria (B. thurningiensis) and Gram negative bacteria (E.coli) of 
various series including 2-substituted-3a,4,9a-tetrahydro-4,9-benzeno-
benz(f)isoindole-1,3-diones: benzimidazoles (3) acetybenz-imidazole 
(4) [26]. A amine derived bis-benzimidazole (5) showed antibacterial 
efficiency against C.albicans, B.proteus, which were designed by the 
systematical structural modification of Fluconazole [27].  A series of 2-
substituted benzimidazoles analogues (6) having potent activity against 
Gram positive bacteria (B.subtilis), Gram negative bacteria (E.coli) and 
antifungal activity for T.virdae [28]. A series of 5-(nitro/bromo)-styryl-
2-benzimidazoles (7) are synthesized showing antitubercular activity 




































The 2-azetidinones derivatives of 2-methyl-1H-
benzimidazoles (8) showing antibacterial activity against B.subtilis 
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(Gram positive) and E.coli (Gram negative) [30]. Some 1-{[5-
(alkyl/aryl)-1,3,4-oxadiazol-2-yl]methyl}-2alkyl-1H-benzimidazoles  (9) 
showing potent activity against Gram positive bacteria (S.aureus 
ATCC29123), (J.mutans MTCC 890) with Gram negative (E.coli) and 



















                             8                                                  9  
The 2-(Amino-/isopropylamino-/chloro-/bromo-)benzimidazoles 
analogues (10) having potent activity against methicillin-resistant 
staphylococcus [32]. The 2-alkene substituted benzimidazoles, 
tetrahydrobenzimidazoles (11). A series 2-(substituted phenyl)-1H-



















10                                                   11                                    12  
The 1-(4-(1H-benzo[d]imidazol-1-yl)phenyl)-3-chloro-4-phenyl aztidin-
2-one (13) [34]. A series of phenyl and benzimidazoles substituted 
benzyl ethers (14) were tested for antibacterial (S.aureus, E.coli) and 













13                                           14  
Substituted 5-[2-(2-methylbenzimidazole-1-yl)ethyl]-3-
diethylaminoethyl (15) were tested against one strain of Gram +ve 
bacteria (Bacillus cereus), Gram –ve bacteria (E. coli) [36]. A series of 
Schiff bases of 4-(4-aminophenyl)-morphine (16) were tested for 
antibacterial (S. aureus, S. epidermis) and antifungal (C. albicans, A. 













15                                     16 
Various N-alkyl and N-acyl derivatives of 2-(4-thiazolyl)-1H-
benzimidazole (17) were screened for their antifungal and antibacterial 
activity (2004) [38]. Some 2-substituted-phenyl-1H-benz-imidazoles-5-
carbonitril (18) with their potent activity against Candida species was 
reported [39]. Synthesis and antiparasitic activity of 1H-benzimidazole 
derivatives (19) were tested against protozoa Giardia lambia, 





















                 17                                        18                               19 
 
5. Other Compounds: 
Some 2-(6-fluorochroman-2-yl)-1-alkyl/acyl/aroyl-1H-
benzimidazoles (20) exhibited anti-bacterial activity against Salmonella 
typhimurium [41]. 
A series of functionalized benzimidazole derivatives by the 
condensation of OPDA with 4-bromobenzoic acid (21) were tested for 
their potential anti-bacterial [42]. A series of actinonin derivatives 
containing a benzimidazole heterocyclic linked as amide isostere (22) 
were evaluated in vitro against S. aureous, K. pneumonia, and Sarcina 
lutea [22]. The O-benzimidazolyl clarithromycin derivatives (23) were 









































                               22                                                                          23 
5.1 Antifungal activity:  
Infectious diseases have been serious and growing threatens 
to human health during the past few decades. The decrease of sensibility 
to anti-microbial agents in current use has also been increasing for a 
great variety of pathogens and the resistance to multiple drugs is more 
and more prevalent for several microorganisms, especially for Gram-
positive bacteria and some intractable fungi. Their inhibitory properties 
as regard representative fungi have been extensively exploited. 
Especially, it is worthy to note that Fluconazole, the first-line triazole-
anti-fungal drug has established an exceptional therapeutic record for 
Candida infections, and become the first choice in the treatment of 
infections by C. albicans and Cryptococcus neoformans due to its potent 
activity, excellent safety profile, and favorable pharmacokinetic 
characteris-tics. However, Fluconazole is not effective against invasive 
aspergillosis and is not fungicidal. In addition, extensive clinical use of 
Fluconazole has resulted in the increasing Fluconazole- resistant C. 
albicans isolates [43]. 
A series of novel spiro [indole-thiazolidinones (24) were 
tested in vitro for anti-fungal activity against Rhizoctonia solani, 
Fusarium oxysporum and Collectotrichum [44]. A series of 2’-
arylsubstituted-1H,10H-[2,5’]-bisbenzimidazolyl-5-carboxamidines (25) 




















                               24                                                 25 
A series of novel 2-substituted benzimi-dazoles (26), 
tetrahydrobenzimidazoles and imidazoles and screened there in vitro 
anti-bacterial anti-fungal activities [46]. A series of novel benzimidazole 


















26                                                  27 
Lipophilicity and anti-fungal activity of some 2-substituted 
benzimidazole derivatives (28) tested against yeast Saccharomyces 
cerevisiae [48]. 
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Anti-bacterial and Anti-fungal Activities of Benzimidazole and 
Benzo-xazole Derivatives (28a-c) against standard strains and 59 















5.2 Antiviral activity:  
Chronic infection with the hepatitis C virus (HCV) is a major 
risk factor for developing cirrhosis and hepatocellular carcinoma. About 
3% of the worldwide population is chronically infected with HCV. A 
preventive vaccine has not been developed and limits of current 
therapeutics include serious side effects and therapy usually lasting 48 
weeks with only a 50% sustained virological response rate. A recent 
major advance was the development of an infectious virus system based 
on the transfection of human hepatoma cells with genomic HCV RNA 
(JFH1) isolated from a patient with fulminant hepatitis. This cell culture 
model allows all stages of the HCV life cycle to be studied [50]. Antiviral 
properties of various benzimidazole derivatives have been reported in a 
variety of studies using different virus strains, such as human 
cytomegalovirus (HCMV), human immunodeficien-cy virus, and 
hepatitis B and C virus. Also, amidino-substituted benzimidazoles, such 
as bis(5-amidino-2-benzimidazolyl) methane (BABIM), showed ability 
to block respiratory syncytial (RS) virus induced cell fusion. In addition, 
introducing amidino moiety to benzimidazole ring was shown to 
possess potent antimicrobial and anti-protozoal activity.  
Major progress has been made in developing infectious HCV 
cell culture systems and these systems have been useful in identifying 
novel HCV anti-viral [50]. A set of heterocyclic benzimidazole 
derivatives (29) bearing amidino substituent at C-5 of benzimidazole 
ring, by introducing various hetero-cyclic nuclei (pyridine, N-methyl-
pyrrole or imida-zole) at C-2, and evaluated their anti-tumor and anti-
viral activities [51]. A series of 4-[1-(substituted aryl/alkyl carbonyl)-
benzoimidazol-2-yl]-benzene sulphonic acids (30,31) were tested for 
anti-fungal activity and compounds 4-[1-(4-Nitrobenzoyl)-1H-
benzoimid-azol-2-yl] benzenesulfonic acid (32) and 4-(1-octadec-9-
enoyl-1H-benzoimidazol-2-yl)-benzenesulfonic acid (33)was found to 
be the most active ones [52]. Some benzimidazoles (34) synthesized by 
refluxing o-phenyldiamine with corresponding carbo-xylic acids and 
evaluated for anti-viral activity against PRSV on plant chenopodiun 
amranticular [53]. A series of 2-arylbenzimidazoles (35) were evaluated 
them for anti-viral activity as well as anti-proliferative. Compounds 
were tested in cell-based assays against viruses’ representative of: i) 
two of the three genera of the Flaviviridae family, i.e. Flaviviruses and 
Pestiviruses; ii) other RNA virus families, such as Retroviridae, 
Picornaviridae, Paramyxoviridae, Rhabdo-viridae and Reoviridae; iii) two 
DNA virus families (Herpesviridae and Poxviridae). Compounds resulted 
moderate activity only against Yellow Fever Virus [54]. Water-soluble 
benzimidazol-2-one derivatives (36) with anti-viral activity in vivo in the 
cotton rat model of RSV infection following administration as a small 
parti-cle aerosol. The acidic compounds demonstrated potent anti-viral 
activity in cell culture [55]. A series of benzimidazole derivatives (37) 
and substituted benzimidazole β-L- and β-D-2’-deoxyribonucleosides 
and evaluated for anti-viral activity against selected RNA and DNA 
viruses including HIV-1, BVDV, YFV, DENV-2, WNV, HBV, HCV and 
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5.3 Antimalarial activity:  
Malaria caused 350-500 million clinical episodes annually 
and result in over one million deaths, most of which affect children 
under 5 years old in sub Saharan Africa. Malaria is the fifth cause of 
death from infectious diseases globally (after respiratory infections, 
HIV/AIDS, diarrhoeal diseases and tuberculosis). In addition to its 
health toll, malaria puts a heavy economic burden on endemic countries 
and contributes to the cycle of poverty people face in many countries. 
Malaria mortality and morbidity began to increase in the 1980s due to a 
combination of factors such as increase in parasite and vector resistance 
to the current anti-malarial drugs and insecticides, the weakening of 
traditional malaria control programs, rapid decentralization and 
integration into deteriorating primary health service, and the 
development of humanitarian crisis situations in many malaria-endemic 
areas. This dramatic increase led to a compelling and urgent necessity 
for new malarial, with mechanisms of action different from the existing 
ones, and to identify new drug targets. Cloroquine has recently been 
shown to inhibit hemozoin formation within the parasite food vacuole. 
This process is also thought to be the molecular target of other quinoline 
anti-malarial. Hemozoin was originally considered to be formed by the 
polymerization of heme, but has now been demonstrated to be a 
crystalline cyclic dimmer of ferriproto-porphyrin IX. Thus, hemozoin 
synthesis, a process unique to the malaria parasite, offers a logical and 
valuable potential target for new anti-malarial drug development. New 
drugs that attack the same vital target of chloroquine but that are not 
subject to the same resistance mechanism would be highly desirable 
[57].   
The activity of N1-(7-chloro-4-quinolyl)-1,4-bis(3-
aminopropyl)piperazine derivative (38) against a chloroquine-resistant 
strain of Plasmodium falciparum in which compound is active showing 
best anti-malarial activity [58]. A series of N-substituted-2-(5-nitrofuran 
or 5-nitrothiophen-2- yl)-3H-benzo[d]imidazole-5-carbohydrazide 
derivatives (39) and screened for their anti-malarial efficacy in rodent 



















38                                               39 
A series of ten novel hybrids from benzimidazole (40) tested 
in vitro against the protozoa Trichomonas virginal’s, Giardia lamblia, 
Entamoeba histolytica, Leishmania mexicana, and Plasmodium berghei 
showed good anti-malarial activity [59]. Vázquez et al. (2006) 
substituted a series of 2-(trifluoromethyl)-1H-Benzimidazole 
derivatives (41) was shows good anti-malarial activity [60]. Several 
series of imidazo [2,1-a] isoindol-5-ol derivatives (42) evaluated against 
Plasmodium falciparum [61]  
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Thiabendazole possessed potent activity against 
gastrointestinal nematodes sparked development of the benzimidazoles 
as broad-spectrum anthelmintic agents. The hundreds of derivatives 
tested, those therapeutically useful have modifications at the 2 and/or 5 
positions of the benzimidazole ring.  This important group of substances 
has found practical applications in a number of fields. Historically, the 
first benzimidazole was prepared, 2,5(or 2,6)-dimethyl benzimidazole 
























Figure 2: Synthesis of 2,5 (or 2,6)-dimethylbenzimidazole 
 
6. Physical properties of benzimidazoles  
The melting point of number of the benzimidazoles indicated 
that the introduction of a substituent into 1-position in general lowers 
the melting point. Benzimidazoles with the imide nitrogen are usually 
soluble in polar solvents and less soluble in organic solvents. With 
introduction of other non-polar substituents in various positions of the 
benzimidazole ring, the solubility in nonpolar solvents is increased. 
Benzimidazole distills unchanged above 300 C̊. Benzimidazoles are 
weakly basic, being somewhat less basic than the imidazoles and are in 
general soluble in dilute acids. Benzimidazoles are also sufficiently 
acidic to be generally soluble in aqueous alkali and form N-metallic 
compounds. The acidic properties of the benzimidazoles, like those of 
the imidazoles, seem to be due to stabilization of ion by resonance. The 
more acidic benzimidazoles may be soluble in less basic solution, such 
as potassium carbonate solution. Evidence was obtained indicating 
molecular association through N-H-N bonds in those compounds 
possessing an unsubstituted NH grouping. The strength of this bond is 
evidently enhanced by resonance of the benzimidazole nucleus. The 
dipole moment of benzimidazole, the values that have been obtaine 
being 3.93-4.08 D (in dioxane)[64].  
 
7. Chemical properties of benzimidazoles [65-69]  
Reactions of the benzimidazole ring: The benzimidazole ring 
possesses a high degree of stability. Benzimidazole is not affected by 
concentrated sulfuric acid, hot hydrochloric acid as well as alkalis. 
Oxidation cleaves the benzene ring of benzimidazole only under 
vigorous conditions. The benzimidazole ring is also quite resistant to 
reduction but under certain conditions the tetrahydro and 
hexahydrobenzimidazoles may be prepared by catalytic reduction. 
Reactions involving 1 and 3-positions: Benzimidazoles form salts e.g. 
with acids readily forms monohydrochloride, mononitrate, monopicrate, 
monoacetate. Alkylations: Benzimidazoles, undergoes alkylation with 
alkyl halides, yielding 1-alkylbenzimidazoles and under more vigorous 














Benzimidazoles also react with acylating, Grignard reagents and metal. 
The benzimidazole also forms mannich bases by reacting formaldehyde 
and piperidne.  
Hydrogenation and dehydrogenation reactions: It was thought that 
benzimidazole ring was stable to reduction. Catalytic reduction of 
benzimidazole even under high pressure with nickel as the catalyst is 
reported to give negative results. 2-Phenylbenzimidazole gives only 2-
cyclohexylbenzimidazole. Hydrogenation of 2-(p-dimethylaminostyryl) 
benzimidazole with nickel at atmospheric pressure saturates only the 















A number of hydrogenated benzimidazoles have been prepared also by 
chemical methods. Hexahydro-2(3H)-benzimidazolone may be obtained 
by the reaction between hexahydro-o-phenylenediamine and phosgene 
in sodium hydroxide solution. Attempted dehydrogenation of 
tetrahydrobenzimidazoles with palladium sponge does not give the 
corresponding benzimidazole but instead a compound of high molecular 
weight.  
Cleavage of the imidazole ring: The imidazole ring of benzimidazoles 
may be cleaved by one of the several methods by reacting with 
pseudobases, acid anhydrides and halide.  
Halogenation: When 2,5(or 2,6)-dimethylbenzimidazole is an aqueous 
acid solution on treatment with saturated solution of bleaching powder 














Reactions involving the 2-methyl or methylene group: The methyl 
group of 2-methylbenzimidazoles is comparable in its activity to the 
methyl group of α-picoline, quinaldine, or methyl ketones and shows 
most of the same reactions of these compounds. The benzimidazoles 
ring, like the pyridine and quinoline ring, because of its electron 
attracting nature imparts a positive character to the carbon atom of the 
2-methyl group. 2-Methylbenzimidazoles, for example, react with 
aromatic aldehydes in aldol type condensations in a manner analogous 
to α-picoline quinaldine.  
Nitration: The nitration of benzimidazoles proceeds readily. In most 
cases nitration appears to take place preferentially at the 5 or 6 position. 
However, the nitro group may also enter the 4 or 7 position, especially if 
the 5 or 6 poition is blocked.  
Reactions involving substituent groups: The various useful 
transformations can be successfully carried out various substituents in 











Reactions of 2-benzimidazolecaboxylic acids: Benzimidazoles 
containing a carboxyl group in the 2-positions readily undergo 
decarboxylation on heating. 2-benzimidazolecarboxylic acid on heating 










Reactions of 2-(α-haloalkyl)benzimidazoles: 2-(α-Chloroisopropyl) 
benzimidazole when refluxed in dry alcoholic solution in the presence of 
pyridine gives a good yield of 2-(α-ethoxyisopropyl)benzimidazoles and 
hence reacts in a manner analogous to tritylchloride (triphenylmethyl 













Reactions of 2-(3H)-Benzimidazolones: 2(3H)-Benzimidazolones (or 
2-hydroxybenz-imidazoles) are extremely stable treatment of 
substances.2 (3H)-benzimidazolone is not split by treatment with 
benzoyl chloride in alkaline solution. 2(3H)-benzimidazolones show 
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many of the reactions of 2-hydroxypyridines and 2-hydroxyquinolines; 
for example, 2(3H)-benzimidazolone with phosphorous oxychloride or 
















2(3H)-Benzimidazolethiones: 2(3H)-Benzimidazolethiones or 2- 
mercaptobenzimidazoles) are generally stable substances and are 
soluble in dilute alkali. Alkylation occurs readily with replacement of the 
mercapto hydrogen to yield S-alkylated derivatives, and a number of 















2-Aminobenzimidazoles: 2-Aminobenzimidazole with acetic anhydride 













Oxidation: Benzimidazoles are stable to oxidation. By vigorous 
conditions of oxidation (potassium permanganate in hot alkaline 
solution) it is partially possible to oxidize benzimidazoles to obtain a 













Because of the stability of the benzimidazoles ring to oxidation it is 
possible to oxidize substituent group without affecting the ring. By the 
oxidation of the substituent groups a variety of benzimidazolecarboxylic 
acids have been prepare.  
 
8. Methods for synthesis of benzimidazoles:  
All synthesis of benzimidazoles starts with benzene 
derivatives possessing nitrogen-containing functional group at position 
ortho. Various strategies for the synthesis of benzimidazoles are 
discussed below.  
From o-phenylenediamines  
By reaction of carboxylic acid and carboxylic acid derivatives: The o-
phenylenediamines react readily with most carboxylic acids to give 2-
substituted benzimidazoles. Also, o-phenylene-diamines and their 
dihydrochlorides also react with various carboxylic acid derivatives like 
anhydrides, ester, amides and acid chlorides to give the corresponding 










By reaction with lactones: Valerolactone when refluxed with o-









H3C   
By reaction with nitriles: Cyanogen bromide reacts with o-
phenylenediamines to give 2-amino-benzimidazoles. The reaction is 
carried out by mixing equimolecular amounts of the reactants in 









By reaction with aldehydes: Under the correct conditions aldehydes 
may reacted with o-phenylene-diamines to give 2-substituted 
benzimidazoles. Due improvement of oxidation reaction was best 








By reaction with ketones: The reaction with a number of ketones, the 
direct elimination of the alkyl group and of hydrogen (as R-H) may be 
assumed to be due to the gain in resonance stabilization on conversion 
to the benzimidazoles.  
By reaction with imino-ethers and imino-thioethers: The synthesis of 
benzimidazoles from imino ethers or imino thioethers and o-
phenylenediamines had been investigated. This reaction was illustrated 
by the preparation of 2-phenylbenzimidazole from o-phenylenediamine 










By reaction with amidines and guanidines: Diphenylformamidine 
gives an 85.5 per cent yield of benzimidazoles when heated at about 









By reaction with urea: o-phenylenediamine dihidrochloride when 











By reaction with carbon disulfide: The reaction was carried out 
generally by heating the reactants in alcoholic solutions with or without 
the addition of alkali to the reaction mix and led to the synthesis of 











By reaction with thiophosgene: The 2(3H)-benzimidazolthione and 5-
methyl-2(3H)-benz-imidazolthione by the reaction of thiophosgene on 
o-phenylenediamine and 3,4-diaminotoulene, respectively. The 3,4-
Diaminobenzenearsonic acid thiophosgene gave 2(3H)-benz-











By reaction of 2-aminobenzimidazoles: 2-Arylaminobenzimidazoles 
were formed by the action of diarylcarbodimides on o-









From monoacyl- and diacyl-o-phenylenediamines: 










By reduction of acetylated o-nitroanilines: N-substituted acylated o-
nitroanilines lead to 1-substituted benzimidazoles. N-methyl-2-nitro-4-
methylacetanilide on reduction gives 1,2,5-trimethylbenzimidazole.  
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From o-aminoazo compounds: The o-aminoazo compounds react with 
aldehydes to form schiffs bases. The resulting schiffs bases were 
undergo isomerization (boiling acetic acid) with the shifting of a 












From phenylurethans: 2(3H)-Benzimidazolone was prepared by 










Advanced methods of synthesis of benzimidazoles: The synthesis of 
various benzimidazoles using a catalytic amount of TiCl4 and silica 
sulfuric acid under mild solvent free conditions and synthesis of 2-
substituted benzimidazoles by microwave in the presence of alumina-
methanesulfonic acid [70-72].  
 
9. Conclusion 
Benzimidazoles are regarded as a promising class of bioactive 
heterocyclic compounds that exhibit a range of biological activities. 
Benzimidazole is the heterocyclic compound formed from benzene and 
imidazole ring containing nitrogen, oxygen sulphor and its derivatives 
are of wide interest because of their diverse biological activity and 
clinical applications, they are remarkably effective compounds both 
with respect to their inhibitory activity and their favourable selectivity 
ratio. Benzimidazole nucleus is a constituent of vitamin-B12. 
Benzimidazoles are regarded as a promising class of bioactive 
heterocyclic compounds that exhibit a range of biological activities like 
anti-microbial, anti-viral, anti-diabetic, anti-cancer, anti-oxidant, anti-
parasitic, anti-helmintics, anti-proliferative, anti-HIV, anti-convulsant, 
anti-inflammatory, anti-hypertensive, anti-neoplastic, proton pump 
inhibitor and anti-trichinellosis. Benzimidazoles exhibit significant 
activity as potential antitumor agents, smooth muscle cell proliferation 
inhibitors, a treatment for intestinal cystitis, and in diverse area of 
chemistry. Some of the important benzimidazole derivatives have been 
reported as thyroid receptor agonist gonadotropin releasing hormone 
receptor antagonists, non-nucleoside HIV-1 reverse transcriptase 
inhibitors and interestingly alkynylbenzimidazoles as modulators of 
metabotropic glutamate receptors. The imidazole core is a common 
moiety in a large number of natural products and pharmacologically 
active compounds. The synthesis of novel benzimidazole derivatives 
remains a main focus of medicinal research. This comprehensive 
overview summarizes the chemistry of different derivative of 
substituted benzimidazole along with their anti-microbial activity 
containing anti-malarial anti-fungal, anti-bacterial, anti-viral activities. 
This comprehensive overview summarizes the chemistry of different 
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